These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 23766333)

  • 1. Short- and long-term mortality and causes of death in HIV/tuberculosis patients in Europe.
    Podlekareva DN; Panteleev AM; Grint D; Post FA; Miro JM; Bruyand M; Furrer H; Obel N; Girardi E; Vasilenko A; Losso MH; Arenas-Pinto A; Caylá J; Rakhmanova A; Zeltina I; Werlinrud AM; Lundgren JD; Mocroft A; Kirk O;
    Eur Respir J; 2014 Jan; 43(1):166-77. PubMed ID: 23766333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberculosis-related mortality in people living with HIV in Europe and Latin America: an international cohort study.
    Podlekareva DN; Efsen AM; Schultze A; Post FA; Skrahina AM; Panteleev A; Furrer H; Miller RF; Losso MH; Toibaro J; Miro JM; Vassilenko A; Girardi E; Bruyand M; Obel N; Lundgren JD; Mocroft A; Kirk O;
    Lancet HIV; 2016 Mar; 3(3):e120-31. PubMed ID: 26939735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for excess mortality and death in adults with tuberculosis in Western Kenya.
    van't Hoog AH; Williamson J; Sewe M; Mboya P; Odeny LO; Agaya JA; Amolloh M; Borgdorff MW; Laserson KF
    Int J Tuberc Lung Dis; 2012 Dec; 16(12):1649-56. PubMed ID: 23131264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality from HIV and TB coinfections is higher in Eastern Europe than in Western Europe and Argentina.
    Podlekareva DN; Mocroft A; Post FA; Riekstina V; Miro JM; Furrer H; Bruyand M; Panteleev AM; Rakhmanova AG; Girardi E; Losso MH; Toibaro JJ; Caylá J; Miller RF; Obel N; Skrahina A; Chentsova N; Lundgren JD; Kirk O;
    AIDS; 2009 Nov; 23(18):2485-95. PubMed ID: 19898216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health care index score and risk of death following tuberculosis diagnosis in HIV-positive patients.
    Podlekareva DN; Grint D; Post FA; Mocroft A; Panteleev AM; Miller RF; Miro JM; Bruyand M; Furrer H; Riekstina V; Girardi E; Losso MH; Caylá JA; Malashenkov EA; Obel N; Skrahina AM; Lundgren JD; Kirk O;
    Int J Tuberc Lung Dis; 2013 Feb; 17(2):198-206. PubMed ID: 23317955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis is associated with non-tuberculosis-related deaths among HIV/AIDS patients in Rio de Janeiro.
    Pacheco AG; Veloso VG; Nunes EP; Ribeiro S; Guimarães MR; Lourenço MC; Mello FC; Grinsztejn B
    Int J Tuberc Lung Dis; 2014 Dec; 18(12):1473-8. PubMed ID: 25517814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS.
    Williams BG; Dye C
    Science; 2003 Sep; 301(5639):1535-7. PubMed ID: 12920302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes after tuberculosis for people with HIV in eastern Europe.
    Kraef C; Bentzon A; Roen A; Bolokadze N; Thompson M; Azina I; Tetradov S; Skrahina A; Karpov I; Mitsura V; Paduto D; Trofimova T; Borodulina E; Mocroft A; Kirk O; Podlekareva DN;
    AIDS; 2023 Nov; 37(13):1997-2006. PubMed ID: 37503671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-year mortality of HIV-positive patients treated for rifampicin- and isoniazid-susceptible tuberculosis in Eastern Europe, Western Europe, and Latin America.
    TB:HIV Study writing Group
    AIDS; 2017 Jan; 31(3):375-384. PubMed ID: 28081036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in response to antiretroviral therapy in HIV-positive patients being treated for tuberculosis in Eastern Europe, Western Europe and Latin America.
    Caro-Vega Y; Schultze A; W Efsen AM; Post FA; Panteleev A; Skrahin A; Miro JM; Girardi E; Podlekareva DN; Lundgren JD; Sierra-Madero J; Toibaro J; Andrade-Villanueva J; Tetradov S; Fehr J; Caylà J; Losso MH; Miller RF; Mocroft A; Kirk O; Crabtree-Ramírez B
    BMC Infect Dis; 2018 Apr; 18(1):191. PubMed ID: 29685113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Feature analysis on patients died from co-infection of Mycobacterium tuberculosis and human immunodeficiency virus in Guangxi, from 2007 to 2012].
    Zheng Z; Tang Z; Lin M; Liu F; Cui Z; Geng W
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Jun; 35(6):695-8. PubMed ID: 25174474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with mortality and default among patients with tuberculosis attending a teaching hospital clinic in Accra, Ghana.
    Burton NT; Forson A; Lurie MN; Kudzawu S; Kwarteng E; Kwara A
    Trans R Soc Trop Med Hyg; 2011 Dec; 105(12):675-82. PubMed ID: 21920570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-associated extrapulmonary tuberculosis in Thailand: epidemiology and risk factors for death.
    Kingkaew N; Sangtong B; Amnuaiphon W; Jongpaibulpatana J; Mankatittham W; Akksilp S; Sirinak C; Nateniyom S; Burapat C; Kittikraisak W; Monkongdee P; Varma JK
    Int J Infect Dis; 2009 Nov; 13(6):722-9. PubMed ID: 19196530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality and loss to follow-up among tuberculosis and HIV co-infected patients in rural southwestern Uganda.
    Nansera D; Bajunirwe F; Elyanu P; Asiimwe C; Amanyire G; Graziano FM
    Int J Tuberc Lung Dis; 2012 Oct; 16(10):1371-6. PubMed ID: 22863182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment outcome, survival and their risk factors among new tuberculosis patients co-infected with HIV during the Ebola outbreak in Conakry].
    Camara A; Sow MS; Touré A; Diallo OH; Kaba I; Bah B; Diallo TH; Diallo MS; Guilavogui T; Sow OY
    Rev Epidemiol Sante Publique; 2017 Nov; 65(6):419-426. PubMed ID: 29066256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical spectrum, risk factors and outcome of immune reconstitution inflammatory syndrome in patients with tuberculosis-HIV coinfection.
    Worodria W; Menten J; Massinga-Loembe M; Mazakpwe D; Bagenda D; Koole O; Mayanja-Kizza H; Kestens L; Mugerwa R; Reiss P; Colebunders R;
    Antivir Ther; 2012; 17(5):841-8. PubMed ID: 22543224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment outcomes of daily anti-tuberculosis treatment in HIV-infected patients seeking care at a private clinic in India.
    Parchure R; Kulkarni V; Gangakhedkar R; Swaminathan S
    Int J Tuberc Lung Dis; 2016 Oct; 20(10):1348-1353. PubMed ID: 27725046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of integrated tuberculosis and human immunodeficiency virus service delivery on patient outcomes.
    Uyei J; Coetzee D; Macinko J; Weinberg SL; Guttmacher S
    Int J Tuberc Lung Dis; 2014 Mar; 18(3):315-21. PubMed ID: 24670569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with death during tuberculosis treatment of patients co-infected with HIV at the Yaoundé Central Hospital, Cameroon: an 8-year hospital-based retrospective cohort study (2006-2013).
    Agbor AA; Bigna JJ; Billong SC; Tejiokem MC; Ekali GL; Plottel CS; Noubiap JJ; Abessolo H; Toby R; Koulla-Shiro S
    PLoS One; 2014; 9(12):e115211. PubMed ID: 25506830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality among tuberculosis patients in the Democratic Republic of Congo.
    Henegar C; Behets F; Vanden Driessche K; Tabala M; Bahati E; Bola V; Van Rie A
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1199-204. PubMed ID: 22871326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.